Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

From molecular signatures to predictive biomarkers: modeling disease pathophysiology and drug mechanism of action

22 Aug 2014

Abstract excerpt

Omics profiling significantly expanded the molecular landscape describing clinical phenotypes. Association analysis resulted in first diagnostic and prognostic biomarker signatures entering clinical utility. However, utilizing Omics for deepening our understanding of disease pathophysiology, and further including specific interference with drug mechanism of action on a molecular process level still sees limited...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Chronic Kidney Disease and Diabetes
Share to Genetic Associations and Epidemiology
Share to Pharmacogenetics and Drug Metabolism

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 25364744
DOI: 10.3389/fcell.2014.00037

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

From molecular signatures to predictive biomarkers: modeling disease pathophysiology and drug mechanism of actionPMID 25364744Read ↗

Discovering a trans-omics biomarker signature that predisposes high risk diabetic patients to diabetic kidney diseaseSemantic proximity Read ↗

Drugs meeting the molecular basis of diabetic kidney disease: bridging from molecular mechanism to personalized medicine.Semantic proximity Read ↗

Identification of hub genes involved in the pathogenesis of diabetic nephropathy: A multi‐omics study integrating machine learning, mendelian randomization and mediation analysisSemantic proximity Read ↗

Identification of druggable targets in acute kidney injury by proteome- and transcriptome-wide Mendelian randomization and bioinformatics analysisSemantic proximity Read ↗

Decoding Kidney Pathophysiology: Omics-Driven Approaches in Precision MedicineSemantic proximity Read ↗

Network medicine: an approach to complex kidney disease phenotypes.Semantic proximity Read ↗

Integrative analyses of biomarkers and pathways for diabetic nephropathySemantic proximity Read ↗

Identification of diagnostic biomarkers for diabetes nephropathy by multi-chip integrated bioinformatics combining machine-learning strategies and mendelian randomizationSemantic proximity Read ↗

Investigate biomarkers and regulatory mechanisms related to RNA modification in diabetic nephropathy through bioinformatics and clinical experimentsSemantic proximity Read ↗

SLC10A2 has prognostic implications for individuals afflicted with diabetic pancreatic cancer, and its associated molecules have the potential to serve as biomarkers for diabetic nephropathySemantic proximity Read ↗

p53 as a Convergent Genetic Modifier in Chronic Kidney Disease: Unifying Genetic Risk and Defining Renal Modulatory DrugsSemantic proximity Read ↗

Systems biology and machine learning approaches identify drug targets in diabetic nephropathySemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.